Skip to main content
Log in

Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure

  • Clinical Correspondence
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Metra M, Torp-Pedersen C, Swedberg K, Cleland JG, DiLenarda A, Komajda M, Remme WJ, Lutiger B, Schgerhag A, Lukas MA, Charlesworth A, Poole-Wilson PA (2005) Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartate in patients with chronic heart failure: results from the COMET trial. Eur Heart J 26:2259–2268

    Article  PubMed  CAS  Google Scholar 

  2. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H (2001) Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 103:1428–1433

    PubMed  CAS  Google Scholar 

  3. Peterson JW, Felker M (2008) Inotropes in the management of acute heart failure. Crit Care Med 36:S106–S111

    Article  Google Scholar 

  4. Eklayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV (2007) Use and impact of inotropes and vasodilatatory therapy in hospitalized patients with severe heart failure. Am Heart J 153:98–104

    Article  Google Scholar 

  5. Simon L, Ghalch B, Puybasset L, Giudicelli JF, Berdeaux A (1995) Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 275:659–666

    PubMed  CAS  Google Scholar 

  6. Borer JS, Fox K, Jaillon P, Lerebours G, Ivabradine Investigators Group (2003) Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina. A randomized, double-blind, multicentered, placebo-controlled trial. Circulation 107:817–823

    Article  PubMed  Google Scholar 

  7. Fox K, Ferrari R, Tendera M, Steg PG, Ford I, BEAUTIFUL Steering Committee (2006) Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary heart disease and left ventricular systolic dysfunction: the morbidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricular dysfunction (BEAUTIFUL) Study. Am Heart J 152:860–866

    Article  PubMed  CAS  Google Scholar 

  8. De Ferrari GM, Mazzuero A, Agnesina L, Bertoletti A, Lettino M, Campana C, Schwartz PJ, Tavazzi L (2008) Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure. Eur J Heart Fail 10:550–555

    Article  PubMed  CAS  Google Scholar 

  9. Hoppe UC, La Rosée K, Larbig R, Erdmann E (2007) Selective inhibition of the pacemaker channel I(f) improves symptoms in severe dilated cardiomyopathy. Clin Res Cardiol 96:243–246

    Article  PubMed  Google Scholar 

  10. Reil JC, Böhm M (2007) The role of heart rate in the development of cardiovascular disease. Clin Res Cardiol 96:585–592

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas Link.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Link, A., Reil, J.C., Selejan, S. et al. Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure. Clin Res Cardiol 98, 513–515 (2009). https://doi.org/10.1007/s00392-009-0038-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-009-0038-9

Keywords

Navigation